Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (Hylaform((R)) from rooster combs and Restylane((R)) from streptococcus) used for soft tissue augmentation
F. Manna et al., Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (Hylaform((R)) from rooster combs and Restylane((R)) from streptococcus) used for soft tissue augmentation, J EUR A D V, 13(3), 1999, pp. 183-192
Citations number
29
Categorie Soggetti
Dermatology
Journal title
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Hyaluronic acid (HA) derivatives have been developed to try to enhance rheo
logical properties of this molecule to make it suitable for various medical
applications. The main dermatological application of HA derivatives is the
augmentation of soft tissues, via injection into the dermis. HA derivative
s are indicated for the correction of cutaneous contour deficiencies of the
skin, particularly in cases of ageing or degenerative lesions or to increa
se lips. Two HA derivatives have been evaluated: Hylaform(R) Viscoelastic G
el (Hylan B), derived from rooster combs and subjected to cross-linking, an
d Restylane(R), produced through bacterial fermentation (streptococci) and
stabilized, as declared by the producer. In both cases the purpose is to im
prove HA rheological characteristics and slow down its degradation once it
is in contact with biological structures. Distribution of particle dimensio
ns, pH, protein concentration and rheological properties have been investig
ated in order to evaluate their reliability as fillers for soft tissue augm
entation. The results of the analyses showed that there are differences bet
ween Rest ylane(R) and Hylaform(R). Especially as far as rheological charac
teristics are concerned, the results outline different structures of the pr
oducts: Hylaform(R) behaves as a strong hydrogel, Restylane(R) as a weak hy
drogel; theologically Hylaform(R) is clearly superior to Restylane(R). Hyla
form(R) contains a definitely minor quantity (about a quarter) of cross-lin
ked hyaluronic acid than Restylane(R). Furthermore, although not declared b
y the manufacturer, Restylane(R) contains protein, resulting from bacterial
fermentation or added to enable cross-linking reaction; the quantity of pr
oteins contained by Restylane(R) can be as much as four times the quantity
contained by Hylaform(R), for the same volume (1 ml). It is evident that Hy
laform(R) offers higher safety margin than Restylane(R). Furthermore, wide
literature and 20 years of clinical experience on hyaluronan derived from r
ooster combs confirm the reliability of this derivative while we did not fi
nd evidence regarding about the safety of HA obtained from streptococcus. (
C) 1999 Elsevier Science B.V. All rights reserved.